Velufenacin

DB21473InvestigationalSmall molecule

Velufenacin is a small molecule drug. The usage of the INN stem '-fenacin' in the name indicates that Velufenacin is a muscarinic receptor antagonist. Velufenacin is under investigation in clinical... Velufenacin is under investigation in clinical trial NCT05282069 (A Study to Evaluate the Efficacy and Safety of DA-8010 in Patients With Overactive Bladder).

Mechanism: Pharmacologically active on Muscarinic acetylcholine receptor M3 and Muscarinic acetylcholine receptor
Curator reviewed
Formula / weight: C₁₉H₂₀ClFN₂O₂ · 362.83 g/mol (avg)
Code names: DA-8010

Resolves to

Compound

UNIIWV3E0S3IQBCAS1648737-78-3ChEMBLCHEMBL5810614

Structure

InChIKeySYBGVVSJNMTWCI-CYBMUJFWSA-NSMILESCN1CC[C@@H](COC(=O)NC2=C(C=CC=C2)C2=CC(Cl)=C(F)C=C2)C1

Targets

P20309CHRM3

What you can answer from here — as of September 13, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

5Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with Velufenacin, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account